about
Nephrotoxic effects of common and emerging drugs of abuse.Illicit use of androgens and other hormones: recent advancesThe Sturm und Drang of anabolic steroid use: angst, anxiety, and aggressionTestosterone modulates cardiac contraction and calcium homeostasis: cellular and molecular mechanismsSynthetic androgens as designer supplementsCulture, psychosomatics and substance abuse: the example of body image drugsMad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviorsAdverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement."I Want It All, and I Want It Now": Lifetime Prevalence and Reasons for Using and Abstaining from Controlled Performance and Appearance Enhancing Substances (PAES) among Young Exercisers and Amateur Athletes in Five European Countries.Intracranial self-stimulation to evaluate abuse potential of drugs.Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implicationsA diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity.Multivitamin and protein supplement use is associated with positive mood states and health behaviors in US Military and Coast Guard personnel.Misuse of medicines in the European Union: a systematic review of the literature.Adrenal steroids uniquely influence sexual motivation behavior in male ratsThe influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy menDevelopment and validation of the appearance and performance enhancing drug use schedule.Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.Hormones and prostate carcinogenesis: Androgens and estrogens.Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review.Relationships between structure, ionization profile and sensitivity of exogenous anabolic steroids under electrospray ionization and analysis in human urine using liquid chromatography-tandem mass spectrometry.Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs.Effectiveness and implementation of a community-based prevention programme targeting anabolic androgenic steroid use in gyms: study protocol of a quasi-experimental control group study.The Misuse of Anabolic-Androgenic Steroids among Iranian Recreational Male Body-Builders and Their Related Psycho-Socio-Demographic factors.Performance-enhancing drugs on the web: a growing public-health issue.Cognitive deficits in long-term anabolic-androgenic steroid users.Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcificationConditional Effects of Appearance and Performance Enhancing Drugs (APEDs) Use on Mood in Powerlifters and Bodybuilders.Eating disorders and anabolic androgenic steroids in males--similarities and differences in self-image and psychiatric symptoms.Mood Symptoms in Steroid Users: The Unexamined Role of Concurrent Stimulant Use.Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF-kBIatrogenic dependence of anabolic-androgenic steroid in an Indian non-athletic woman.Testosterone enhances risk tolerance without altering motor impulsivity in male rats.The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.Forensic aspects of drug-induced violence.Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.Illicit Drug Use Among Gym-Goers: a Cross-sectional Study of Gym-Goers in Sweden.
P2860
Q21558458-D0DA53B5-6330-44C3-8D94-719C7BB160CDQ26824840-374F5B1E-13D9-4D87-80D5-DC7DDFC79B62Q27693678-7B601346-1862-40F6-B225-2FF4FE4F560CQ28084477-057600B1-9584-4DFA-A30F-87CA155C8FBFQ28263449-57A16C04-F611-4BC6-A9E6-8C3BE5167F28Q28728748-69DF60B0-5D11-4723-A9A2-5592689B80D8Q30364736-3EC57B9D-57DF-4FB2-981F-C09D43615504Q30409171-5D0A8D29-78AD-4C43-B67F-3EE0716038EFQ33710886-87D401EE-FC25-499B-A69A-DEE056792FADQ33845750-724FB5FB-84E1-4BD7-8699-B790D278E6B5Q33872639-E6204356-F494-4AA2-93FB-E00D0ECBFBF9Q34033811-487ABF2F-88D3-4C4A-97C2-7F1F5FF25E57Q34194015-2377CBDC-74A9-4537-B0E6-FF8F6841A981Q34273774-E76454DC-2E28-40B1-9945-E8B527A6FB47Q34443307-961C5E9E-17E4-43BF-87EB-48B5CF2637FFQ34543722-9C9102F6-05AF-4C00-96BE-9F8BE95973F0Q34701306-0304841C-0F5E-46C6-97D1-81486086283AQ35173334-DA62D923-7B92-4D3E-A6E4-3F1132389B64Q35434335-E440D58E-CC7D-4E14-AD6A-3A5017B58D59Q35555918-DCEE43E0-70A0-40B4-8A5A-46F401CE3F1EQ35687198-7A18A81D-6D43-4A8D-BFF7-89A55BA34B4CQ35710568-0BB5368B-A018-4E5C-9C6C-A4E03F19B109Q35744480-F7D99196-15C8-41A5-8EDD-9CEB1C4F511EQ35964561-8313AE4A-5017-4597-8CFE-F0D289C4BC73Q36205008-2546CDED-AB6D-442E-8A65-9DBA0A2266F2Q36495734-4C2C2702-45FE-4D47-9692-BC093ACA1E96Q36626914-F65DA6A3-F649-4E9F-8F36-37DA38BE9692Q36717843-85C99092-F552-481E-885F-773C46858F2AQ36814985-CE00312D-0E9C-4EF3-BD16-3132C91DE197Q36896074-68FCB501-48E3-4711-B608-E473EE92365AQ37116369-7013C0F3-BA36-4D4A-B9D4-FB833E284189Q37164529-541A732F-1156-4B74-97E0-06DD649BEBDCQ37446868-1579D591-F416-4007-BF51-02DDD1A6AA76Q37570668-540AAC4D-2B7C-4E1E-B414-5374AD38D18AQ37573732-EAAD789C-2494-4034-AC3F-790E1845276CQ37653046-03871D5C-6AE0-4831-A8AC-FB11E4E86720Q37973043-E77FA2F2-41BC-4227-8DE3-943AC048F3E7Q38589015-A1CA6AC4-D0F4-4E35-A01E-B84E170986DBQ38592105-6C454DC8-9232-46A1-8CFC-0F14255AA26EQ38602616-3A2ED24C-1036-412E-80A4-06B62C6B259D
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Illicit anabolic-androgenic steroid use
@ast
Illicit anabolic-androgenic steroid use
@en
type
label
Illicit anabolic-androgenic steroid use
@ast
Illicit anabolic-androgenic steroid use
@en
prefLabel
Illicit anabolic-androgenic steroid use
@ast
Illicit anabolic-androgenic steroid use
@en
P2093
P2860
P1476
Illicit anabolic-androgenic steroid use
@en
P2093
Gen Kanayama
Harrison G Pope
James I Hudson
P2860
P304
P356
10.1016/J.YHBEH.2009.09.006
P577
2009-09-18T00:00:00Z